Feb 03, 2025
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
Oct 10, 2024
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
Oct 01, 2024
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
Sep 10, 2024
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
Aug 06, 2024
InMode to Present at Upcoming Investor Conferences
Aug 01, 2024
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M
Jul 31, 2024
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
Jul 11, 2024
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
May 16, 2024
InMode to Present at Jefferies Healthcare Conference
May 02, 2024
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M;
Apr 15, 2024
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
Apr 09, 2024
InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024
Mar 04, 2024
InMode to Present at March Investor Conferences and Events
Feb 13, 2024
InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M
Jan 16, 2024
InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024, Expects Q4 Revenue Between $126.0M-$126.5M